These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11405656)

  • 1. Amphiphilic anionic analogues of galactosylceramide: synthesis, anti-HIV-1 activity, and gp120 binding.
    Faroux-Corlay B; Greiner J; Terreux R; Cabrol-Bass D; Aubertin AM; Vierling P; Fantini J
    J Med Chem; 2001 Jun; 44(13):2188-203. PubMed ID: 11405656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of single- and double-chain fluorocarbon and hydrocarbon galactosyl amphiphiles and their anti-HIV-1 activity.
    Faroux-Corlay B; Clary L; Gadras C; Hammache D; Greiner J; Santaella C; Aubertin AM; Vierling P; Fantini J
    Carbohydr Res; 2000 Jul; 327(3):223-60. PubMed ID: 10945673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of glycolipid analogues that disrupt binding of HIV-1 gp120 to galactosylceramide.
    Weber KT; Hammache D; Fantini J; Ganem B
    Bioorg Med Chem Lett; 2000 May; 10(10):1011-4. PubMed ID: 10843204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-Glycoside analogues of beta-galactosylceramide with a simple ceramide substitute: synthesis and binding to HIV-1 gp120.
    Augustin LA; Fantini J; Mootoo DR
    Bioorg Med Chem; 2006 Feb; 14(4):1182-8. PubMed ID: 16216516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric synthesis of water-soluble analogues of galactosylceramide, an HIV-1 receptor: new tools to study virus-glycolipid interactions.
    Villard R; Hammache D; Delapierre G; Fotiadu F; Buono G; Fantini J
    Chembiochem; 2002 Jun; 3(6):517-25. PubMed ID: 12325007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-HIV activity of semisynthetic derivatives of andrographolide and computational study of HIV-1 gp120 protein binding.
    Uttekar MM; Das T; Pawar RS; Bhandari B; Menon V; Nutan ; Gupta SK; Bhat SV
    Eur J Med Chem; 2012 Oct; 56():368-74. PubMed ID: 22858223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of human immunodeficiency virus type 1 gp120 binding to liposomes containing galactosylceramide.
    Long D; Berson JF; Cook DG; Doms RW
    J Virol; 1994 Sep; 68(9):5890-8. PubMed ID: 8057468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tryptophan dendrimers that inhibit HIV replication, prevent virus entry and bind to the HIV envelope glycoproteins gp120 and gp41.
    Rivero-Buceta E; Doyagüez EG; Colomer I; Quesada E; Mathys L; Noppen S; Liekens S; Camarasa MJ; Pérez-Pérez MJ; Balzarini J; San-Félix A
    Eur J Med Chem; 2015 Dec; 106():34-43. PubMed ID: 26513643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4.
    Yang QE; Stephen AG; Adelsberger JW; Roberts PE; Zhu W; Currens MJ; Feng Y; Crise BJ; Gorelick RJ; Rein AR; Fisher RJ; Shoemaker RH; Sei S
    J Virol; 2005 May; 79(10):6122-33. PubMed ID: 15857997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The galactosyl ceramide/sulfatide receptor binding region of HIV-1 gp120 maps to amino acids 206-275.
    Bhat S; Mettus RV; Reddy EP; Ugen KE; Srikanthan V; Williams WV; Weiner DB
    AIDS Res Hum Retroviruses; 1993 Feb; 9(2):175-81. PubMed ID: 8457384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico design of novel broad anti-HIV-1 agents based on glycosphingolipid β-galactosylceramide, a high-affinity receptor for the envelope gp120 V3 loop.
    Andrianov AM; Kornoushenko YV; Kashyn IA; Kisel MA; Tuzikov AV
    J Biomol Struct Dyn; 2015; 33(5):1051-66. PubMed ID: 24942968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, gp120 binding and anti-HIV activity of fatty acid esters of 1,1-linked disaccharides.
    Bachan S; Fantini J; Joshi A; Garg H; Mootoo DR
    Bioorg Med Chem; 2011 Aug; 19(16):4803-11. PubMed ID: 21783371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Density dependent interaction of polymeric analogs of beta-galactosyl ceramide with GP120 of human immunodeficiency virus 1.
    Fujita E; Nishimura SI
    Carbohydr Lett; 2000; 4(1):53-60. PubMed ID: 11469338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120.
    Bhat S; Spitalnik SL; Gonzalez-Scarano F; Silberberg DH
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7131-4. PubMed ID: 1871126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of HIV-1 envelope-mediated fusion by synthetic batzelladine analogues.
    Bewley CA; Ray S; Cohen F; Collins SK; Overman LE
    J Nat Prod; 2004 Aug; 67(8):1319-24. PubMed ID: 15332849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into the interaction between the gp120 and the HIV receptor in human sperm (human.sperm/gp120/galactoglycerolipid/antigalactosylceramide/seminolip id/spermatogonia).
    Brogi A; Presentini R; Moretti E; Strazza M; Piomboni P; Costantino-Ceccarini E
    J Reprod Immunol; 1998 Dec; 41(1-2):213-31. PubMed ID: 10213312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between structure, aggregation behaviour and cellular toxicity of anti-HIV catanionic analogues of galactosylceramide.
    Blanzat M; Perez E; Rico-Lattes I; Lattesa A; Gulik A
    Chem Commun (Camb); 2003 Jan; (2):244-5. PubMed ID: 12585412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and evaluation of potential inhibitors of HIV gp120-CD4 interactions.
    Boussard C; Klimkait T; Mahmood N; Pritchard M; Gilbert IH
    Bioorg Med Chem Lett; 2004 May; 14(10):2673-6. PubMed ID: 15109676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of human immunodeficiency virus type I (HIV-1) gp120 to galactosylceramide (GalCer): relationship to the V3 loop.
    Cook DG; Fantini J; Spitalnik SL; Gonzalez-Scarano F
    Virology; 1994 Jun; 201(2):206-14. PubMed ID: 8184533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivalent catanionic GalCer analogs derived from first generation dendrimeric phosphonic acids.
    Pérez-Anes A; Stefaniu C; Moog C; Majoral JP; Blanzat M; Turrin CO; Caminade AM; Rico-Lattes I
    Bioorg Med Chem; 2010 Jan; 18(1):242-8. PubMed ID: 19942442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.